Wang S, Mahalingam S, Merits A
Rev Med Virol. 2025; 35(2):e70030.
PMID: 40064592
PMC: 11893376.
DOI: 10.1002/rmv.70030.
Yin P, Sobolik E, May N, Wang S, Fayed A, Vyshenska D
PLoS Pathog. 2025; 21(1):e1012859.
PMID: 39804924
PMC: 11759387.
DOI: 10.1371/journal.ppat.1012859.
Larkin C, Dunn M, Shoemaker J, Klimstra W, Faeder J
bioRxiv. 2025; .
PMID: 39764060
PMC: 11703215.
DOI: 10.1101/2024.12.13.628424.
Cao V, Loeanurit N, Hengphasatporn K, Hairani R, Wacharachaisurapol N, Prompila N
Emerg Microbes Infect. 2023; 12(2):2270074.
PMID: 37842770
PMC: 10653753.
DOI: 10.1080/22221751.2023.2270074.
Jones R, Hons M, Rabah N, Zamarreno N, Arranz R, Reguera J
Proc Natl Acad Sci U S A. 2023; 120(12):e2213934120.
PMID: 36913573
PMC: 10041110.
DOI: 10.1073/pnas.2213934120.
Advances in the Development of Small Molecule Antivirals against Equine Encephalitic Viruses.
Ogorek T, Golden J
Viruses. 2023; 15(2).
PMID: 36851628
PMC: 9958955.
DOI: 10.3390/v15020413.
The alphavirus nonstructural protein 2 NTPase induces a host translational shut-off through phosphorylation of eEF2 via cAMP-PKA-eEF2K signaling.
Treffers E, Tas A, Scholte F, de Ru A, Snijder E, Van Veelen P
PLoS Pathog. 2023; 19(2):e1011179.
PMID: 36848386
PMC: 9997916.
DOI: 10.1371/journal.ppat.1011179.
Self-Amplifying RNA Vaccine Candidates: Alternative Platforms for mRNA Vaccine Development.
Schmidt C, Schnierle B
Pathogens. 2023; 12(1).
PMID: 36678486
PMC: 9863218.
DOI: 10.3390/pathogens12010138.
Cell-Type-Dependent Role for nsP3 Macrodomain ADP-Ribose Binding and Hydrolase Activity during Chikungunya Virus Infection.
Kim T, Abraham R, Pieterse L, Yeh J, Griffin D
Viruses. 2022; 14(12).
PMID: 36560748
PMC: 9787352.
DOI: 10.3390/v14122744.
The life cycle of the alphaviruses: From an antiviral perspective.
Skidmore A, Bradfute S
Antiviral Res. 2022; 209:105476.
PMID: 36436722
PMC: 9840710.
DOI: 10.1016/j.antiviral.2022.105476.
G3BP/Rin-Binding Motifs Inserted into Flexible Regions of nsP2 Support RNA Replication of Chikungunya Virus.
Wang S, Merits A
J Virol. 2022; 96(21):e0127822.
PMID: 36226983
PMC: 9645214.
DOI: 10.1128/jvi.01278-22.
Expression of Alphavirus Nonstructural Protein 2 (nsP2) in Mosquito Cells Inhibits Viral RNA Replication in Both a Protease Activity-Dependent and -Independent Manner.
Cherkashchenko L, Rausalu K, Basu S, Alphey L, Merits A
Viruses. 2022; 14(6).
PMID: 35746799
PMC: 9228716.
DOI: 10.3390/v14061327.
Genomic evolution of the Coronaviridae family.
Zmasek C, Lefkowitz E, Niewiadomska A, Scheuermann R
Virology. 2022; 570:123-133.
PMID: 35398776
PMC: 8965632.
DOI: 10.1016/j.virol.2022.03.005.
Mayaro Virus Non-Structural Protein 2 Circumvents the Induction of Interferon in Part by Depleting Host Transcription Initiation Factor IIE Subunit 2.
Ishida R, Cole J, Lopez-Orozco J, Fayad N, Felix-Lopez A, Elaish M
Cells. 2021; 10(12).
PMID: 34944018
PMC: 8700540.
DOI: 10.3390/cells10123510.
Alphavirus-Induced Membrane Rearrangements during Replication, Assembly, and Budding.
Elmasri Z, Nasal B, Jose J
Pathogens. 2021; 10(8).
PMID: 34451448
PMC: 8399458.
DOI: 10.3390/pathogens10080984.
Alphavirus Virulence Determinants.
Rangel M, Stapleford K
Pathogens. 2021; 10(8).
PMID: 34451445
PMC: 8401390.
DOI: 10.3390/pathogens10080981.
Specificity Studies of the Venezuelan Equine Encephalitis Virus Non-Structural Protein 2 Protease Using Recombinant Fluorescent Substrates.
Bozoki B, Motyan J, Hoffka G, Waugh D, Tozser J
Int J Mol Sci. 2020; 21(20).
PMID: 33081394
PMC: 7593941.
DOI: 10.3390/ijms21207686.
Small-Molecule Inhibitors of Chikungunya Virus: Mechanisms of Action and Antiviral Drug Resistance.
Kovacikova K, van Hemert M
Antimicrob Agents Chemother. 2020; 64(12).
PMID: 32928738
PMC: 7674028.
DOI: 10.1128/AAC.01788-20.
Membrane binding and rearrangement by chikungunya virus capping enzyme nsP1.
Gottipati K, Woodson M, Choi K
Virology. 2020; 544:31-41.
PMID: 32174512
PMC: 7103501.
DOI: 10.1016/j.virol.2020.02.006.
Benzamidine ML336 inhibits plus and minus strand RNA synthesis of Venezuelan equine encephalitis virus without affecting host RNA production.
Skidmore A, Adcock R, Jonsson C, Golden J, Chung D
Antiviral Res. 2019; 174:104674.
PMID: 31816348
PMC: 6935354.
DOI: 10.1016/j.antiviral.2019.104674.